News Releases

ATLANTA , July 24, 2017 /PRNewswire/ -- Second Quarter Highlights: Revenues Increased Two Percent Year-over-Year to $47.8 Million ; Non-GAAP Revenues Increased Four Percent Year-over-Year Gross Margins were 69 Percent GAAP Net Income was $3.2 Million , or $0.09 Per Fully Diluted Common Share;

ATLANTA , July 10, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 second quarter financial results will be released on Monday, July 24, 2017 after the market closes.  On Tuesday, July 25,

ATLANTA , April 27, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that it will participate in the upcoming Deutsche Bank 42 nd Annual Health Care Conference on Wednesday, May 3, 2017 at the

ATLANTA , April 27, 2017 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that results from the On-X aortic heart valve PROACT study will be presented in a late-breaking session at the American Association

ATLANTA , April 26, 2017 /PRNewswire/ -- First Quarter Highlights: Revenues Increased Five Percent Year-over-Year to $45.1 Million ; Non-GAAP Revenues Increased Five Percent Year-over-Year Gross Margins were 65 Percent; Non-GAAP Gross Margins were 70 Percent GAAP Net Income was $2.2 Million , or

ATLANTA , April 11, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2017 first quarter financial results will be released on Wednesday, April 26, 2017 after the market closes.  On Thursday,

Provides 2017 Financial Guidance ATLANTA , Feb. 15, 2017 /PRNewswire/ -- Fourth Quarter Highlights: Revenues Increased 13 Percent Year-over-Year to $45.0 Million ; Non-GAAP Revenues Decreased Two Percent Year-over-Year Gross Margins Increased to 69 Percent; Non-GAAP Gross Margins Increased to 71

ATLANTA , Feb. 7, 2017 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that 2016 fourth quarter and year-end financial results will be released on Wednesday, February 15, 2017 after the market closes. 

ATLANTA , Nov. 10, 2016 /PRNewswire/ --  CryoLife, Inc. (NYSE: CRY), a leading medical device and tissue processing company focused on cardiac surgery, announced today that Pat Mackin , Chairman, President and Chief Executive Officer, will present at two investor conferences in November 2016 .

Increases 2016 Financial Guidance ATLANTA , Oct. 26, 2016 /PRNewswire/ -- Third Quarter Highlights: Revenue Increased 23 Percent Year-over-Year to $45.3 Million ; Non-GAAP Revenues Increased Six Percent Year-over-Year Gross Margins Increased to 66 Percent; Non-GAAP Gross Margins Increased to 67